DK1165065T3 - Slugetabletter med højt indhold af N-acetylcystein - Google Patents

Slugetabletter med højt indhold af N-acetylcystein

Info

Publication number
DK1165065T3
DK1165065T3 DK00920520T DK00920520T DK1165065T3 DK 1165065 T3 DK1165065 T3 DK 1165065T3 DK 00920520 T DK00920520 T DK 00920520T DK 00920520 T DK00920520 T DK 00920520T DK 1165065 T3 DK1165065 T3 DK 1165065T3
Authority
DK
Denmark
Prior art keywords
acetylcysteine
high levels
containing high
tablets containing
swallowing tablets
Prior art date
Application number
DK00920520T
Other languages
Danish (da)
English (en)
Inventor
Franco Castegini
Alessandro Grassano
Riccardo Barina
Italo Zuliani
Giovanni Gurrieri
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of DK1165065T3 publication Critical patent/DK1165065T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00920520T 1999-04-06 2000-03-21 Slugetabletter med højt indhold af N-acetylcystein DK1165065T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000704A IT1311907B1 (it) 1999-04-06 1999-04-06 Compresse deglutibili ad alto contenuto di n-acetilcisteina.
PCT/EP2000/002464 WO2000059500A1 (en) 1999-04-06 2000-03-21 Swallowable tablets with high content of n-acetylcysteine

Publications (1)

Publication Number Publication Date
DK1165065T3 true DK1165065T3 (da) 2003-09-01

Family

ID=11382595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920520T DK1165065T3 (da) 1999-04-06 2000-03-21 Slugetabletter med højt indhold af N-acetylcystein

Country Status (15)

Country Link
EP (1) EP1165065B1 (de)
CN (1) CN1159004C (de)
AT (1) ATE239463T1 (de)
AU (1) AU4106800A (de)
BR (1) BR0008657A (de)
CA (1) CA2361843C (de)
CO (1) CO4970828A1 (de)
DE (1) DE60002570T2 (de)
DK (1) DK1165065T3 (de)
EA (1) EA003878B1 (de)
ES (1) ES2197087T3 (de)
HU (1) HU228823B1 (de)
IT (1) IT1311907B1 (de)
PT (1) PT1165065E (de)
WO (1) WO2000059500A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US7993578B2 (en) 2004-10-29 2011-08-09 Depuy Spine, Inc. Methods and kits for aseptic filling of products
DK2407166T3 (da) * 2009-03-13 2013-10-07 Toyama Chemical Co Ltd Tablet og granuleret pulver indeholdende 6-fluor-3-hydroxy-2-pyrazin-carboxamid
CN105687177A (zh) * 2009-07-15 2016-06-22 小利兰·斯坦福大学托管委员会 N-乙酰半胱氨酸组合物以及改善对乙酰氨基酚的治疗效能的方法
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN102028657B (zh) * 2010-12-02 2012-05-23 海南美兰史克制药有限公司 乙酰半胱氨酸脂质体固体制剂
CN102144978B (zh) * 2011-04-11 2013-03-13 南京正科制药有限公司 一种乙酰半胱氨酸颗粒及其制备工艺
CN102743369A (zh) * 2012-06-19 2012-10-24 苏州朗易生物医药研究有限公司 一种乙酰半胱氨酸的药物组合物及其制备方法
ITMI20130874A1 (it) * 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina
CN104784116B (zh) * 2015-04-15 2017-05-24 武汉诺贝药业有限公司 一种n‑乙酰半胱氨酸口服制剂
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN110292569B (zh) * 2019-07-15 2021-11-02 广东人人康药业有限公司 一种乙酰半胱氨酸胶囊及其制备方法
CN112843008A (zh) * 2021-02-07 2021-05-28 广东赛康制药厂有限公司 一种乙酰半胱氨酸片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88150A0 (en) * 1987-11-02 1989-06-30 Merck & Co Inc Pharmaceutical tablet compositions containing phthalizine acetic acid compounds
ES2077757T5 (es) * 1990-10-19 2001-06-01 Spirig Ag Pharmazeutische Prap Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
AU4106800A (en) 2000-10-23
HUP0200646A2 (hu) 2002-07-29
HU228823B1 (en) 2013-05-28
IT1311907B1 (it) 2002-03-20
EA200100947A1 (ru) 2002-04-25
EP1165065B1 (de) 2003-05-07
CA2361843A1 (en) 2000-10-12
CA2361843C (en) 2008-10-14
DE60002570T2 (de) 2004-02-26
CN1345236A (zh) 2002-04-17
DE60002570D1 (de) 2003-06-12
ES2197087T3 (es) 2004-01-01
BR0008657A (pt) 2001-12-18
WO2000059500A1 (en) 2000-10-12
CN1159004C (zh) 2004-07-28
ATE239463T1 (de) 2003-05-15
CO4970828A1 (es) 2000-11-07
EP1165065A1 (de) 2002-01-02
EA003878B1 (ru) 2003-10-30
ITMI990704A1 (it) 2000-10-06
PT1165065E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
DK1165065T3 (da) Slugetabletter med højt indhold af N-acetylcystein
LUC00155I1 (de)
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
DK2295052T3 (da) Anvendelse af ritonavir til forbedring af farmakokinetikken af lægemidler, der metaboliseres af cytochrom P450
GEP20063799B (en) Tropane derivatives useful in therapy
NO20062098L (no) Faststofftilstandmontelukast
MX2007003321A (es) Derivados heterociclicos y su uso como agentes terapeuticos.
MY136643A (en) Pyrimidine derivatives for inhibition of cell-proliferation
DE69410121D1 (en) Dihydro pyrazolopyrrole
MY115662A (en) Novel compounds with analgesic effect
MXPA04001889A (es) Inhibidores de la alquin-aril fosfodiesterasa-4.
EA200300323A1 (ru) ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ)
EA200200119A1 (ru) β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
DE60010316D1 (de) Magnesiumomeprazol
ATE360428T1 (de) Analgetisches arzneimittel
GB0212410D0 (en) Organic compounds
BRPI0212195B8 (pt) composições contendo pectina e ácido ascórbico
BG106922A (en) Heterocyclic amide derivatives
MY106728A (en) Substituted isoxazole and isothiazole derivatives.
NO20020669L (no) Fenantrolin-7-on-derivater og deres terapeutiske anvendelser
GB0206200D0 (en) Pharmaceutical compositions
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.
DE60013849D1 (de) Ascidideminderivate und ihre therapeutische verwendung
MX9804797A (es) Nuevos compuestos con efecto analgesico.
CA2198875A1 (en) Quinazolinone pharmaceuticals and use thereof